Literature DB >> 16467950

Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders.

Nick C Patel1, M Lynn Crismon, Alan Shafer, Anthony De Leon, Molly Lopez, Daniel C Lane.   

Abstract

BACKGROUND: Evaluation of symptom presentation and antipsychotic response based on ethnicity in children and adolescents with schizophrenia is limited. The purpose of this naturalistic, retrospective database study was to compare symptom presentation of children and adolescents of different ethnicities with schizophrenia-spectrum disorders, and response to risperidone.
METHOD: African-American (n = 38), Caucasian (n = 30), or Hispanic (n = 37) youths started on risperidone were eligible. Child Behavior Checklist (CBCL) total, internalizing, and externalizing scores were evaluated at baseline, 90 days, 1 year, and 2 year intervals.
RESULTS: At baseline, Hispanic patients had lower CBCL externalizing scores than African-Americans or Caucasians. African-Americans showed significant differences in CBCL total, internalizing, and externalizing scores at 90 days compared to baseline. Hispanics showed improvement in CBCL internalizing scores over the 2 year period. No significant improvements were observed in Caucasians. African-American patients had significantly lower CBCL total at 90 days compared to Hispanic patients. No significant difference existed in 2 year hospitalization rates between groups.
CONCLUSIONS: These findings suggest that ethnicity may play a role in symptom presentation and treatment response to risperidone for children and adolescents with schizophrenia-spectrum disorders. Future studies in children and adolescents are necessary to examine ethnospecific differences in antipsychotic use and treatment response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467950     DOI: 10.1007/s00127-006-0036-4

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  20 in total

Review 1.  Cultural and contextual influences in mental health help seeking: a focus on ethnic minority youth.

Authors:  Ana Mari Cauce; Melanie Domenech-Rodríguez; Matthew Paradise; Bryan N Cochran; Jennifer Munyi Shea; Debra Srebnik; Nazli Baydar
Journal:  J Consult Clin Psychol       Date:  2002-02

2.  Do minorities in the United States receive fewer mental health services than whites?

Authors:  Karen E Lasser; David U Himmelstein; Steffie J Woolhandler; Danny McCormick; David H Bor
Journal:  Int J Health Serv       Date:  2002       Impact factor: 1.663

Review 3.  Ethnicity and antipsychotic response.

Authors:  E J Frackiewicz; J J Sramek; J M Herrera; N M Kurtz; N R Cutler
Journal:  Ann Pharmacother       Date:  1997-11       Impact factor: 3.154

4.  Neuroleptic dosing in Hispanic and Asian Inpatients with schizophrenia.

Authors:  Y Collazo; R Tam; J Sramek; J Herrera
Journal:  Mt Sinai J Med       Date:  1996 Oct-Nov

5.  Cross-ethnic symptom differences in schizophrenia: the influence of culture and minority status.

Authors:  J S Brekke; C Barrio
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

6.  Role of ethnicity in predicting antipsychotic medication adherence.

Authors:  Jayme L Opolka; Karen L Rascati; Carolyn M Brown; P Joseph Gibson
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

7.  Evaluation of expressed emotion in schizophrenia: a comparison of Caucasians and Mexican-Americans.

Authors:  Alex Kopelowicz; Roberto Zarate; Veronica Gonzalez; Steven R Lopez; Paula Ortega; Nora Obregon; Jim Mintz
Journal:  Schizophr Res       Date:  2002-05-01       Impact factor: 4.939

8.  A tri-ethnic examination of symptom expression on the positive and negative syndrome scale in schizophrenia spectrum disorders.

Authors:  Concepcion Barrio; Ann Marie Yamada; Hazel Atuel; Richard L Hough; Simon Yee; Bryan Berthot; Patricia A Russo
Journal:  Schizophr Res       Date:  2003-04-01       Impact factor: 4.939

9.  Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study.

Authors:  Edyta J Frackiewicz; John M Herrera; John J Sramek; Yasmine Collazo; William B Lawson
Journal:  Psychiatry       Date:  2002       Impact factor: 2.458

10.  Ethnicity and diagnosis in patients with affective disorders.

Authors:  Stephen M Strakowski; Paul E Keck; Lesley M Arnold; Jacqueline Collins; Rodgers M Wilson; David E Fleck; Kimberly B Corey; Jennifer Amicone; Victor R Adebimpe
Journal:  J Clin Psychiatry       Date:  2003-07       Impact factor: 4.384

View more
  4 in total

1.  Exploring Biologic Predictors Response Disparities to Atypical Antipsychotics among Blacks: A Quasi-Systematic Review.

Authors:  Rebecca N Jerome; Jill M Pulley; Nila A Sathe; Shanthi Krishnaswami; Alyssa B Dickerson; Katherine J Worley; Consuelo H Wilkins
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

2.  Longitudinal treatment outcome of African American and Caucasian patients with first episode psychosis.

Authors:  Huijun Li; Shaun M Eack; Debra M Montrose; Jean M Miewald; Matcheri Keshavan
Journal:  Asian J Psychiatr       Date:  2011-10-12

3.  Differences in Total Score of Positive and Negative Syndrome Scale between Bataknese and Javanese Men with Schizophrenia Receiving Risperidone Treatment.

Authors:  Manahap Cerarius F Pardosi; Bahagia Loebis; Muhammad Surya Husada; Nazli M Nasution; Elmeida Effendy; Mustafa M Amin; Vita Camellia
Journal:  Open Access Maced J Med Sci       Date:  2019-07-29

4.  Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.

Authors:  Neetha N Vijayan; Sujatha Bhaskaran; Linda V Koshy; Chandrasekhar Natarajan; Lekshmy Srinivas; Chandrasekharan M Nair; Priya M Allencherry; Moinak Banerjee
Journal:  Behav Brain Funct       Date:  2007-07-25       Impact factor: 3.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.